“Mendelian randomization”: using natural genetic variation to assess the causal role of modifiable risk factors in observational studies

由 Neeland, Ian J., Kozlitina, Julia
發表在 Circulation (2017)

Aging and Diabetes: Shifting the Risk Trajectory With High-Sensitivity Cardiac Troponins

由 Neeland, Ian J., de Lemos, James A.
發表在 Diabetes Care (2020)

The Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management

由 Neeland, Ian J., Poirier, Paul, Després, Jean-Pierre
發表在 Circulation (2018)

Response to Letter Regarding Article, “Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management”

由 Neeland, Ian J., Poirier, Paul, Després, Jean-Pierre
發表在 Circulation (2018)

Prevention and Treatment of Heart Failure We Want to Pump You Up

由 Lavie, Carl J., Carbone, Salvatore, Neeland, Ian J.
發表在 JACC Cardiovasc Imaging (2020)

A Safety Evaluation of Empagliflozin for the Treatment of Type 2 Diabetes

由 Neeland, Ian J., Salahuddin, Usman, McGuire, Darren K.
發表在 Expert Opin Drug Saf (2016)

Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population

由 Shemisa, Kamal, Bhatt, Anish, Cheeran, Daniel, Neeland, Ian J.
發表在 Curr Heart Fail Rep (2017)

Tipping the Scales for Older Adults: Time to Consider Body Fat Assessment and Management for Optimal Atherosclerotic Cardiovascular Disease and Stroke Prevention?

由 Simpkins, Alexis N., Neeland, Ian J., Lavie, Carl J.
發表在 J Am Heart Assoc (2021)

Evolving considerations in the management of patients with left bundle branch block and suspected myocardial infarction

由 Neeland, Ian J., Kontos, Michael C., de Lemos, James A.
出版 2012

Sodium-glucose co-transporter inhibition in the treatment of diabetes: Sweetening the pot

由 Alvarez, Carlos A, Neeland, Ian J, McGuire, Darren K
發表在 Diab Vasc Dis Res (2015)

Waist Circumference as Measure of Abdominal Fat Compartments

由 Grundy, Scott M., Neeland, Ian J., Turer, Aslan T., Vega, Gloria Lena
出版 2013

Ethnic and Gender Susceptibility to Metabolic Risk

由 Grundy, Scott M., Neeland, Ian J., Turer, Aslan T., Vega, Gloria Lena
出版 2014

21(st) Century Advances in Multimodality Imaging of Obesity for Care of the Cardiovascular Patient

由 Neeland, Ian J., Yokoo, Takeshi, Leinhard, Olof Dahlqvist, Lavie, Carl J.
發表在 JACC Cardiovasc Imaging (2020)

Do Neighborhoods Matter Differently for Movers and Non-Movers?: Analysis of Weight Gain in the Longitudinal Dallas Heart Study

由 Leonard, Tammy, Ayers, Colby, Das, Sandeep, Neeland, Ian J., Powell-Wiley, Tiffany
發表在 Health Place (2017)

The association of lymphotoxin-beta receptor with the subsequent diagnosis of incident gastrointestinal cancer: results from the Dallas Heart Study

由 Bergstrom, Colin P., Beg, Muhammad S., Ayers, Colby, Gupta, Arjun, Neeland, Ian J.
發表在 J Gastrointest Oncol (2020)

Effects of Visceral Adiposity on Glycerol Pathways in Gluconeogenesis

由 Neeland, Ian J., Hughes, Connor, Ayers, Colby R., Malloy, Craig R., Jin, Eunsook S.
發表在 Metabolism (2016)

Impact of Empagliflozin in Patients with Diabetes and Heart Failure

由 Pham, David, De Albuquerque Rocha, Natalia, McGuire, Darren K., Neeland, Ian J.
發表在 Trends Cardiovasc Med (2016)

Association of urinary sodium-to-potassium ratio with obesity in a multiethnic cohort(1)(2)(3)(4)

由 Jain, Nishank, Minhajuddin, Abu T, Neeland, Ian J, Elsayed, Essam F, Vega, Gloria L, Hedayati, S Susan
出版 2014

Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome

由 Boumosleh, Jocelyne Matar, Grundy, Scott M., Phan, Jennifer, Neeland, Ian J., Chang, Alice, Vega, Gloria Lena
發表在 J Endocr Soc (2017)

Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME...

由 Neeland, Ian J., Kasai, Takatoshi, Inzucchi, Silvio E., Wojeck, Brian S., Yaggi, Henry K., Johansen, Odd Erik
發表在 Diabetes Care (2021)